Reponex Pharmaceuticals A/S announced that Professor Søren Nielsen has been the interim CEO in Reponex since 11 October 2022 and has formerly been in the board of directors for Reponex. Professor Nielsen has chosen to focus his future efforts to support AKI Therapeutics A/S and in RepoCeuticals A/S. Therefore, it has been decided that Thomas Kaas Selsø, who is already CEO of Pharma Equity Group, will take over as CEO of Reponex.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.258 DKK | +11.21% | +30.96% | -40.00% |
17/05 | Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/05 | Pharma Equity Group A/S announced that it expects to receive DKK 1 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 38.33M | |
+23.41% | 81.64B | |
+84.59% | 20.62B | |
+14.45% | 17.89B | |
+12.98% | 14.95B | |
+5.98% | 13.43B | |
+3.51% | 11.53B | |
+6.01% | 10.86B | |
+32.49% | 10.07B | |
-0.73% | 9.89B |
- Stock Market
- Equities
- PEG A Stock
- News Pharma Equity Group A/S
- Reponex Pharmaceuticals A/S Announces CEO Changes